In the United States, the distribution of the vaccine developed by Johnson & Johnson company against coronavirus, which was approved by the Food and Drug Administration on February 27, started.
Director of the US Center for Disease Control and Prevention (CDC), Dr. Rochelle Walensky shared the information that the 3.9 million doses of the Johnson & Johnson vaccine, which set out last night, will reach health centers in the states and begin to be administered.
“The vaccine provides convenience in application thanks to its properties”
Pointing out that the vaccine in question was shot in a single dose, Walensky said that since the vaccine can be preserved at the temperature of the refrigerator, it will facilitate transportation and application, thus speeding up the vaccination.
It had received emergency use approval
Johnson & Johnson vaccine became the third vaccine approved for emergency use in the USA after Pfizer / BioNTech and Moderna.
It was announced that the vaccine, which was tried on 44 thousand people and whose single dose was said to be 66 percent effective against COVID-19, provided strong protection against disease and death.
The total number of vaccines in the country approached 75 million
According to the CDC, which tracks the COVID-19 vaccination statistics in the country, the total number of vaccines made throughout the country has approached 75 million.
The first dose of COVID-19 vaccine was given to more than 49.8 million people in the country, and the second dose of COVID-19 vaccine to more than 24.8 million people.